financetom
Business
financetom
/
Business
/
Walgreens to pay $595 million to settle COVID test contract dispute
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Walgreens to pay $595 million to settle COVID test contract dispute
Feb 25, 2025 3:15 PM

(Reuters) -Walgreens said it had entered into a settlement agreement with telemedicine provider Everly Health Solutions as part of which the pharmacy chain operator will pay the company $595 million over a contract dispute for COVID-19 testing.

The settlement, payable within two business days, comes after a judge in Delaware recently ruled against Walgreens' bid to set aside an arbitration ruling. Walgreens had faced paying a substantially higher amount, nearly $1 billion.

Everly Health, formerly known as PWNHealth, initiated the arbitration in 2022, claiming that Walgreens broke the terms of a 2020 business contract during the pandemic.

Walgreens had used Everly's physician network to order COVID-19 tests that customers requested on Walgreens' website, according to court filings.

(Reporting by Sneha S K in Bengaluru)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Best Buy tops profit expectations as membership program revamp pays off
Best Buy tops profit expectations as membership program revamp pays off
May 30, 2024
(Reuters) -Best Buy ( BBY ) beat Wall Street estimates for quarterly profit on Thursday as benefits from its membership program and cost-saving efforts helped overcome a steeper-than-expected drop in comparable sales. While consumers in the United States are still shy on big-ticket discretionary spending, Best Buy ( BBY ) is hoping to see sales normalize this year as shopping...
Celcuity Prices $60 Million Common Stock Offering
Celcuity Prices $60 Million Common Stock Offering
May 30, 2024
08:04 AM EDT, 05/30/2024 (MT Newswires) -- Celcuity ( CELC ) said Thursday it has priced its offering of about 3.8 million common shares at $15.50 per share for gross proceeds of $60 million. Investors, including BVF Partners, Vivo Capital, Eventide Asset Management, have agreed to purchase shares in the offering. Proceeds from the offering, which is expected to close...
EHealth CFO John Stelben to Retire; John Dolan Named Successor
EHealth CFO John Stelben to Retire; John Dolan Named Successor
May 30, 2024
07:59 AM EDT, 05/30/2024 (MT Newswires) -- EHealth ( EHTH ) said Thursday that Chief Financial Officer John Stelben is retiring and will step down from his position at the end of August. The company named John Dolan, eHealth's chief accounting officer, as CFO effective Aug. 31. Dolan will also serve as the company's principal financial and accounting officer. Stelben...
Sherlock Bio evaluates over-the-counter rapid test for STIs, aims launch in 2025
Sherlock Bio evaluates over-the-counter rapid test for STIs, aims launch in 2025
May 30, 2024
By Bhanvi Satija May 30 (Reuters) - Sherlock Bio said on Thursday it had begun a trial of its over-the-counter rapid test for detecting sexually transmitted infections (STI) such as chlamydia and gonorrhea, and aims to launch it by mid-2025. The Massachusetts-based startup expects to become the first to launch a prescription-free rapid test for the infections, which affected 2.3...
Copyright 2023-2026 - www.financetom.com All Rights Reserved